Sparteine is a class 1a antiarrhythmic agent, a sodium channel blocker. The deficient debrisoquine hydroxylation of Sparteine is due to the absence of P-450IID1 protein in the livers of poor metabolizers.

(±)-5-hydroxyl-1-(4'-hydroxyphenyl)-7-phenyl-3-heptanone have digestibility inhibition in vitro in cow rumen fluid.

Isogambogenic acid inhibits angiogenesis and may be a viable drug candidate in anti-angiogenesis therapy.